1921
Volume 100, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Hyperreactive malarial splenomegaly syndrome (HMSS) is a rare cause of splenomegaly in the Western world. Hyperreactive malarial splenomegaly syndrome is caused by an aberrant immunological response to chronic malaria exposure in endemic areas. Revised Fakunle’s criteria may be helpful for diagnosis: persistent splenomegaly (> 10 cm below the costal margin), increased anti- antibodies, increased IgM levels, exclusion of other causes of splenomegaly or malignancy, and a favorable response to antimalarial treatment. We describe the case of a 16-year-old patient, who recently arrived in Belgium from Guinea with a history of splenomegaly and B symptoms in whom HMSS diagnosis was achieved, thanks to the loop-mediated isothermal amplification method. To our knowledge, this is also the first described case treated by dihydroartemisinin/piperaquine.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0765
2019-03-11
2020-09-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/100/5/tpmd180765.html?itemId=/content/journals/10.4269/ajtmh.18-0765&mimeType=html&fmt=ahah

References

  1. Bhatia KK, Crane GG, 1989. HLA heterozygosity and hyperreactive malarious splenomegaly in the Upper Watut Valley of Papua New Guinea. P N G Med J 32: 277286.
    [Google Scholar]
  2. Fakunle YM, Onyewotu II, Greenwood BM, Mohammed I, Holborow EJ, 1978. Cryoglobulinaemia and circulating immune complexes in tropical splenomegaly syndrome. Clin Exp Immunol 31: 5558.
    [Google Scholar]
  3. Bisoffi Z, Leoni S, Angheben A, Beltrame A, Eseme FE, Gobbi F, Lodesani C, Marocco S, Buonfrate D, 2016. Chronic malaria and hyper-reactive malarial splenomegaly: a retrospective study on the largest series observed in a non-endemic country. Malar J 15: 230.
    [Google Scholar]
  4. Van den Ende J, van Gompel A, van den Enden E, Taelman H, Vanham G, Vervoort T, 2000. Hyperreactive malaria in expatriates retourning from sub-Saharan Africa. Trop Med Int Health 5: 607611.
    [Google Scholar]
  5. McGregor A, Doherty T, Lowe P, Chiodini P, Newsholme W, 2015. Hyperreactive malarial splenomegaly syndrome–can the diagnostic criteria be improved? Am J Trop Med Hyg 93: 573576.
    [Google Scholar]
  6. Mothe B, Lopez-Contreras J, Torres OH, Munoz C, Domingo P, Gurgui M, 2008. A case of hyper-reactive malarial splenomegaly. The role of rapid antigen-detecting and PCR-based tests. Infection 36: 167169.
    [Google Scholar]
  7. Cheaveau J et al., 2018. Clinical validation of a commercial LAMP test for ruling out malaria in returning travelers: a prospective diagnostic trial. Open Forum Infect Dis 5: ofy260.
    [Google Scholar]
  8. Ponce C et al., 2017. Diagnostic accuracy of loop-mediated isothermal amplification (LAMP) for screening patients with imported malaria in a non-endemic setting. Parasite 24: 53.
    [Google Scholar]
  9. Cook J et al., 2015. Loop-mediated isothermal amplification (LAMP) for point-of-care detection of asymptomatic low-density malaria parasite carriers in Zanzibar. Malar J 14: 4348.
    [Google Scholar]
  10. Puente S, Rubio JM, Subirats M, Lago M, Gonzalez-Lahoz J, Benito A, 2000. The use of PCR in the diagnosis of hyper-reactive malarial splenomegaly (HMS). Ann Trop Med Parasitol 94: 559563.
    [Google Scholar]
  11. Fakunle YM, 1981. Tropical splenomegaly. Part 1: tropical Africa. Clin Haematol 10: 963975.
    [Google Scholar]
  12. Bates I, Bedu-Addo G, 1997. Review of diagnostic criteria of hyper-reactive malarial splenomegaly. Lancet 349: 1178.
    [Google Scholar]
  13. Fakunle YM, Greenwood BM, 1980. Mortality in tropical splenomegaly syndrome, Trans R Soc Trop Med Hyg 74: 419.
    [Google Scholar]
  14. Leoni S, Buonfrate D, Angheben A, Gobbi F, Bisoffi Z, 2015. The hyper-reactive malarial splenomegaly: a systematic review of the literature. Malar J 14: 185.
    [Google Scholar]
  15. Camara B, Kantambadouno JB, Martin-Blondel G, Berry A, Alvarez M, Benoit-Vical F, Delmont J, Bouchaud O, Marchou B, 2009. Hyperreactive malarial splenomegaly: three clinical cases and literature review. Med Mal Inf 39: 2935.
    [Google Scholar]
  16. Masfrancx D, De Munter P, Devos T, 2013. A 75-years -old missionary with fever, splenomegaly and pancytopenia. Acta Clinica Belgica 68: 225228.
    [Google Scholar]
  17. Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, Kariuki S, Nahlen BL, Lal AA, Udhayakumar V, 2002. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 359: 13111312.
    [Google Scholar]
  18. De Franceschi L, Sada S, Andreoli A, Angheben A, Marocco S, Bisoffi Z, 2005. Sickle cell disease and hyperreactive malarial splenomegaly (HMS) in young immigrants from Africa. Blood 106: 44154417.
    [Google Scholar]
  19. De Iaco G, Saleri N, Perandin F, Gulletta M, Ravizzola G, Manca N, Signorini L, Matteelli A, Prestini K, Castelli F, 2008. Case report: hyper-reactive malarial splenomegaly in a patient with human immunodeficiency virus. Am J Trop Med Hyg 78: 239240.
    [Google Scholar]
  20. Puente S, Subirats M, Benito A, Rubio JM, Gonzalez-Lahoz JM, 2001. Hyperreactive malarial splenomegaly in Europeans: report of five cases. J Travel Med 8: 322324.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0765
Loading
/content/journals/10.4269/ajtmh.18-0765
Loading

Data & Media loading...

  • Received : 20 Sep 2018
  • Accepted : 07 Dec 2018
  • Published online : 11 Mar 2019
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error